Endothelial dysfunction has been implicated in thrombotic microangiopathy in patients with severe COVID-19, with increased circulating endothelial cells and plasma levels of soluble ICAM-1, VCAM-1, and P-selectin [5,36,40]. This evidence concerns the gene ICAM1 and thrombotic microangiopathy.